4.6 Article

Chemotherapeutic Activity of Pitavastatin in Vincristine Resistant B-Cell Acute Lymphoblastic Leukemia

Related references

Note: Only part of the references are listed.
Letter Gastroenterology & Hepatology

Global prediction of primary liver cancer incidences and mortality in 2040

Chenxi Li et al.

JOURNAL OF HEPATOLOGY (2023)

Article Chemistry, Analytical

A sensitive liquid chromatographic-mass spectrometry method for the quantification of vincristine in whole blood collected with volumetric absorptive microsampling

Lisa T. van der Heijden et al.

Summary: A method using VAMS devices was developed and validated for the quantification of vincristine in whole blood from pediatric oncology patients.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2023)

Article Chemistry, Multidisciplinary

A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children

A. Laura Nijstad et al.

Summary: This study investigated the pharmacokinetics of vincristine, a chemotherapeutic agent, in different age groups and found that the binding capacity of vincristine to beta-tubulin decreases with increasing age, suggesting that young children can tolerate higher doses of the drug.

PHARMACEUTICAL RESEARCH (2022)

Article Biochemistry & Molecular Biology

Loss of the redox mitochondrial protein mitoNEET leads to mitochondrial dysfunction in B-cell acute lymphoblastic leukemia

Werner J. Geldenhuys et al.

Summary: B-cell acute lymphoblastic leukemia (ALL) affects both pediatric and adult patients. Resistant tumor cells contribute to minimal residual disease, leading to poor clinical outcomes in some patients. Targeting mitochondrial oxidative phosphorylation (OXPHOS) in the treatment of refractory leukemic cells is a potential novel approach. In this study, knockout of mitoNEET in REH leukemic cells led to changes in mitochondrial function and ultrastructure, decreased OXPHOS capacity, increased reactive oxygen species, and decreased proliferation when exposed to cytarabine.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Review Oncology

Toward Therapeutic Targeting of Bone Marrow Leukemic Niche Protective Signals in B-Cell Acute Lymphoblastic Leukemia

Marjorie C. Delahaye et al.

Summary: B-cell acute lymphoblastic leukemia (B-ALL) is a common malignancy in children, and new chemotherapy combinations have improved outcomes for young patients. The interaction between leukemic cells and their microenvironment plays a crucial role in the prognosis of B-ALL patients.

FRONTIERS IN ONCOLOGY (2021)

Article Multidisciplinary Sciences

Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia

Limei Wu et al.

Summary: Chemoresistance and relapse are major challenges in the treatment of acute lymphoblastic leukemia (ALL). The study identifies QC as a sensitizer for AraC and establishes a QC-CASIN regimen to improve leukemia eradication in ALL, showing limited efficacy in secondary transplanted recipients.

NATURE COMMUNICATIONS (2021)

Review Cell Biology

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells

Yibo Fu et al.

Summary: Mitochondria play important roles in the chemoresistance of pancreatic cancer by affecting apoptosis, metabolism, mtDNA metabolism, and mitochondrial dynamics. Targeting certain factors in mitochondria may improve the sensitivity of pancreatic cancer cells to chemotherapeutic agents.

CELLS (2021)

Review Chemistry, Multidisciplinary

Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective

Alessandro Allegra et al.

Summary: Conventional chemotherapy has limitations in treating hematological malignancies, while immunotherapy shows promising results despite facing challenges. Nanotechnology has the potential to overcome these challenges and enhance the effectiveness of cancer immunotherapy.

NANOMATERIALS (2021)

Review Cell Biology

A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia

Seyed Mohammadreza Bolandi et al.

Summary: Acute myeloid leukemia (AML) is a heterogeneous disease with a poor prognosis and remarkable resistance to chemotherapeutic agents. The bone marrow niche plays a critical role in the initiation and persistence of the disease, and in drug resistance of the leukemic stem cell (LSC) population, through supporting LSC survival and mediating changes in metabolic pathways.

CELLS (2021)

Review Oncology

Statins: a repurposed drug to fight cancer

Wen Jiang et al.

Summary: Statins, as HMG-CoA reductase inhibitors, not only lower cholesterol and improve cardiovascular risk, but also show potential as anti-cancer drugs. However, evidence on their anti-cancer efficacy is inconsistent, with further research needed to determine if they are more effective against certain molecular subtypes of cancer.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Multidisciplinary Sciences

Co-culture model of B-cell acute lymphoblastic leukemia recapitulates a transcription signature of chemotherapy-refractory minimal residual disease

Stephanie L. Rellick et al.

Summary: In this study, an in vitro cell model was developed to investigate a population of treatment-refractory cells in B-cell acute lymphoblastic leukemia (ALL) characterized by dormant, chemotherapy-resistant tumor cells. Through RNA-Seq analysis, the transcriptional signature of these cells was characterized and found to be similar to expression patterns in MRD cells from patients. Genes and signaling pathways common between these cells were identified as potential therapeutic targets for future studies.

SCIENTIFIC REPORTS (2021)

Article Chemistry, Multidisciplinary

Pyrvinium Pamoate Use in a B cell Acute Lymphoblastic Leukemia Model of the Bone Tumor Microenvironment

Rajesh R. Nair et al.

PHARMACEUTICAL RESEARCH (2020)

Article Cell Biology

Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a

Naeun Lee et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Review Pharmacology & Pharmacy

Contribution of the bone marrow stromal cells in mediating drug resistance in hematopoietic tumors

Wei-Chih Chen et al.

CURRENT OPINION IN PHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

The MitoNEET Ligand NL-1 Mediates Antileukemic Activity in Drug-Resistant B-Cell Acute Lymphoblastic Leukemia

Werner J. Geldenhuys et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Review Biochemistry & Molecular Biology

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

Edith Emmings et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Biotechnology & Applied Microbiology

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Chemistry, Medicinal

Novel compounds that target lipoprotein lipase and mediate growth arrest in acute lymphoblastic leukemia

Rajesh R. Nair et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

Review Biochemistry & Molecular Biology

Mitochondria and cancer chemoresistance

Flora Guerra et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2017)

Article Hematology

Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype

Blake S. Moses et al.

EXPERIMENTAL HEMATOLOGY (2016)

Article Oncology

Bone Marrow Microenvironment Niche Regulates miR-221/222 in Acute Lymphoblastic Leukemia

Blake S. Moses et al.

MOLECULAR CANCER RESEARCH (2016)

Article Biotechnology & Applied Microbiology

Pitavastatin suppressed liver cancer cells in vitro and in vivo

He-Yi You et al.

ONCOTARGETS AND THERAPY (2016)

Article Medicine, Research & Experimental

Pharmacokinetic Properties of Single- and Multiple-Dose Pitavastatin Calcium Tablets in Healthy Chinese Volunteers

Zhu Luo et al.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2015)

Article Oncology

The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo

Min-Wu Chao et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)

Article Pediatrics

Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk

Marjet J. A. M. Braamskamp et al.

JOURNAL OF PEDIATRICS (2015)

Article Peripheral Vascular Disease

Pitavastatin: An overview

Yasushi Saito

ATHEROSCLEROSIS SUPPLEMENTS (2011)

Review Biochemistry & Molecular Biology

Akt, FoxO and regulation of apoptosis

Xinbo Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)

Review Cell Biology

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

Maria M. Mihaylova et al.

NATURE CELL BIOLOGY (2011)

Review Pharmacology & Pharmacy

The bone marrow microenvironment as a sanctuary for minimal residual disease in CML

Rajesh R. Nair et al.

BIOCHEMICAL PHARMACOLOGY (2010)

Review Multidisciplinary Sciences

Recent progress in the biology and physiology of sirtuins

Toren Finkel et al.

NATURE (2009)

Article Hematology

Targeting the bone marrow microenvironment in hematologic malignancies

WS Dalton et al.

SEMINARS IN HEMATOLOGY (2004)

Article Biochemistry & Molecular Biology

Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice

T Egawa et al.

LIPIDS (2003)